Recurrent pregnancy loss (RPL) is a common disorder during early gestation. Recent evidence suggests that T helper 1 (Th1)-type immunity is associated with unsuccessful pregnancy especially in women with RPL of otherwise unknown etiology, while Th2-type immunity is associated with pregnancy success. Interleukin (IL)-1 may influence Th1/Th2 immune responsiveness and has been implicated in the establishment of successful pregnancy. In the present study, we investigated polymorphism of the IL-1␤ gene (IL1B) in women with a history of RPL. Significant increases in the frequencies of IL1B promoter region variants IL1-511C and IL1B-31T were found in women with a history of RPL. Increased frequencies of these two variants and their homozygotes were found only in cases having evidence of Th1 immunity to trophoblast as determined by IFN-␥ production of peripheral blood mononuclear cells (PBMCs) stimulated with a trophoblast cell-line extract. Significantly higher IFN-␥ production by PBMCs in response to trophoblast correlated with variant IL1B-511C and its homozygocity in women with RPL. These results suggest that variants −511C and −31T in the IL1B promoter region confer risk for RPL associated with Th1 immunity to trophoblast antigens.
Recurrent pregnancy loss (RPL), defined as three or more first trimester spontaneous abortions, is an important women's health problem. In approximately 50% of cases the etiology remains unknown. 1, 2 Recent studies in rodents provided evidence indicating that predominant T helper 2 (Th2)-type cytokine production at the fetalmaternal interface is associated with successful gestation; while Th1-type immunity is incompatible with pregnancy success. 3, 4 Studies in women have suggested that Th1-type immunity to trophoblast antigens 5, 6 and defective Th2 cytokine production by decidual T cells are associated with RPL.
7 Th1-type immunity may contribute to reproductive failure, since Th1 cytokines such as interferon-gamma (IFN-␥) and tumor necrosis factor-alpha (TNF-␣) have been demonstrated to disrupt a number of reproductive process in vitro. 8, 9 Potential molecular and genetic mechanism(s) underlying these phenomena remain unknown. A growing body of evidence has 20 September 2001 shown that polymorphism of cytokine genes influences cytokine production and may be associated with susceptibility to certain infectious, inflammatory and autoimmune diseases. [10] [11] [12] [13] [14] Cytokines in the IL-1 system (IL-1␣, IL-1␤ and IL-1 receptor antagonist (IL-1Ra)) are produced at the maternal-fetal interface during early pregnancy. 15 The IL-1 system may be involved in the regulation of Th1/Th2 cytokine production, since IL-1 can function as a costimulator for Th2 cell generation in both rodents and humans [16] [17] [18] [19] and may influence IFN-␥ production mediated by natural killer (NK) and T cells. 20, 21 Moreover, IL-1 has been implicated in implantation, 22 and trophoblast growth and invasion. 23 It was recently reported that levels of IL-1␤ mRNA were decreased in the endometrium of women with a history of recurrent pregnancy loss. 24 The genes of the IL-1 system are polymorphic. Biallelic base substitution (C to T) polymorphism has been described at positions −511, −31 and +3953 bases away from the transcriptional start site of the IL-1␤ gene (IL1B). 14, 25, 26 There is also a tandem repeat polymorphism in the IL-1Ra gene (IL1RN). 10 Recent studies have shown that polymorphism of these genes influences cytokine production and susceptibility to certain infectious, inflammatory and malignant diseases. [12] [13] [14] It was also reported that IL1RN polymorphism was associated with recurrent pregnancy loss. 27 In the present study, we investigated polymorphisms of the IL1B gene and Th1 cytokine production in women with RPL.
We performed a retrospective case-controlled study in 59 Caucasian women who attended the Recurrent Pregnancy Loss Clinic within the Center for Reproductive Medicine at Brigham and Women's Hospital between November 1995 and July 1996.
All of these women had a history of three or more first trimester spontaneous abortions of unexplained etiology following a thorough clinical evaluation and laboratory testing involving negative cervical cultures for organisms associated with pregnancy loss (Chlamydia, Mycoplasma, Ureaplasma, and Group B Streptococcus), negative anti-phospholipid antibodies, normal parental karyotypes, normal hormone testing and a normal intrauterine cavity. In addition, none of these women had a history of a recent infection or had a history of autoimmunity. An additional 30 healthy Caucasian women who had a history of at least two successful pregnancies with no pregnancy loss served as fertile controls. To address a possible statistical type I error for our first database, another separate group of 72 Caucasian women with a history of RPL (recruited from our clinic between August 1996 and March 1997) and 42 fertile Caucasian women were subsequently included in a second database. These women met the criteria described above. All women in the study were recruited and consented by Institutional Review Board approved protocols. All of the women with a history of RPL in our two databases had been routinely tested for Th1 immunity to trophoblast as described previously 5 by assaying IFN-␥ produced by peripheral blood mononuclear cells (PBMCs) stimulated with a protein extract derived from the trophoblast lineage cell line Jeg-3. 28 This cell line is endocrinologically and antigenically similar to normal invasive trophoblast. 29, 30 Peripheral blood samples were collected from women who were not pregnant and had at least two normal menstrual cycles since their last delivery or pregnancy loss. None of the women were on medications other than multivitamins. We have previously demonstrated higher production of the Th1 type cytokine IFN-␥ and lower production of the Th2 cytokine IL-10 by PBMCs in a subgroup of women with unexplained RPL; 5, 6 while less than 3% of fertile women have had a positive IFN-␥ response in our assay system. Based on PBMC IFN-␥ production to trophoblast antigen challenge, we divided women with RPL into Th1(+) and Th1(−) subgroups which were similar in age (range: 24-42 years) and number of prior losses (mean 3.873, range 3-11 for Th1(+) groups and mean 3.95, range 3-7 for Th1(−) groups). Women whose PBMCs produced at least 50 pg/ml of IFN-␥ and two-fold over background (not stimulated) levels following exposure to trophoblast extracts in vitro were designated as the RPL Th1(+) subgroup. The mean IFN-␥ level of the RPL Th1(+) group was 215.49 ± 34 pg/ml in the first database series and 165.4 ± 35.4 pg/ml in the second database series. Women in the RPL Th1(−) subgroup did not produce IFN-␥ over background levels.
Our initial experiments using restriction fragment length polymorphism (RFLP) analysis for IL1B polymorphism revealed that variants at the loci of IL1B in our fertile control group were in Hardy-Weinberg equilibrium, and the frequency of the variant IL1B-511C of the Genes and Immunity IL1B promoter region was significantly higher in women with a history of RPL, compared with fertile controls in the first database series (66.9% vs 50%, respectively; P = 0.035; Table 1 ). We confirmed this difference between another RPL group and fertile controls in separate experiments (69.4% vs 52.3%, respectively; P = 0.011; Table 1 ). The frequency of the variant IL1B-31T was also increased in the RPL groups. There was no significant difference in the distributions of the alleles of IL1B at position +3953 and of IL1RN among our study groups. These data suggest that polymorphism of the IL1B promoter region is associated with RPL.
We further determined whether the increased frequency of variants IL1B-511C and IL1B-31T in women with a history of RPL was associated with Th1 immunity to trophoblast. Analysis in the first database series revealed a significantly increased frequency of IL1B-511C in the RPL Th1(+) group, compared with fertile controls (72.9% vs 50%, respectively; P = 0.011; Table 2 ). A similar increase in the frequency of the IL1B-31T in the RPL Th1(+) group was found (71.4% vs 48.3%, respectively; P = 0.029; Table 2 ). Thus, we hypothesized that IL1B polymorphism was associated with Th1 immunity to trophoblast. To test this hypothesis, we analyzed a second database series, and again found a significantly increased frequency of IL1B-511C (80.6% vs 52.3%, respectively; P = 0.0003) and IL1B-31T (79.2% vs 52.3%, respectively; P = 0.0007) in the Th1(+) group, compared with fertile controls (Table 2 ). However, we observed no significant difference in the IL1B-511C and IL1B-31T allele frequency between the RPL Th1(−) group and fertile controls in either of our database series.
The increased frequency of these variants in the RPL Th1(+) groups correlated with an increased frequency of their homozygosity. There was an increased frequency of homozygotes for IL1B-511C and IL1B-31T in the Th1(+) RPL group in both database series, compared with fertile controls (Table 2) . We also observed a decreased frequency of the homozygotes for variant IL1B-511T in the RPL Th1(+) groups (Table 2 ). No significant difference in the IL1B-511C and IL1B-31T allele frequency or their homozygotes was found between either of our RPL Th1(−) groups and fertile controls. These results suggest that homozygosity for IL1B-511C and IL1B-31T confers susceptibility to RPL associated with Th1-type immunity to trophoblast.
In our fertile control and study groups, the alleles at IL1B-511 were in strong linkage disequilibrium with those at IL1B-31T, since more than 91% of cases being homozygous for IL1B-511C were also homozygous for IL1B-31T. The same was true for IL1B-511T and IL1B-31C homozygotes and for heterozygotes of these variants.
We next analyzed the relationship between variants at IL1B-511 and trophoblast extract-induced IFN-␥ production by PBMCs in women with RPL. As shown in Figure 1a , high production of IFN-␥ occurred more frequently in IL1B-511C carriers (C + ) than in IL1B-511C noncarriers (C − ) who had RPL (median level 60.2 pg/ml vs 1.5 pg/ml, respectively; P = 0.005). The IL1B-511C/C genotype was associated with high IFN-␥ production in response to trophoblast antigens, compared with the IL1B-511T/T genotype in women with RPL (median level 63 pg/ml vs 1.5 pg/ml, respectively; P = 0.0165; Figure 1b ). IFN-␥ production was also increased in individuals with the IL1B-511C/T genotype, compared with DNA was isolated from PBMCs of study and control subjects using the QIAamp DNA minikit (QIAGEN Valencia, CA, USA). Alleles at the loci of IL1B were typed using polymerase chain reaction (PCR)-RFLP methods as described elsewhere. 25, 26, 35 Tandem repeat polymorphism in the second intron of IL1RN was analyzed by PCR-gel electrophoresis as described. 13 a Number of alleles. Data were statistically analyzed by Fisher's exact test (two-tailed) with the aid of INSTAT (GraphPad, San Diego, CA, USA). Levels of significance were reported as P values (P Ͻ 0.05 considered statistically significant). those with IL1B-511T/T (median level 43.2 pg/ml vs 1.5 pg/ml). These results were consistent with our hypothesis that polymorphisms of the IL1B promoter region influences Th1 immunity to trophoblast antigens in women with RPL.
To further evaluate the specificity of IFN-␥ secretion to trophoblast extracts, we challenged PBMCs from a group of 20 women with a history of RPL with a protein extract from Jeg-3 cells, red blood cell membrane and allogenic PBMC extracts. We found that red blood cell membrane and allogenic PBMC extracts did not induce IFN-␥ production in any of the cases, whereas seven cases demon- Figure 1 Correlation of trophoblast extract-induced PBMC IFN-␥ production with IL1B-511 genotype in women with a history of RPL. PBMCs from study subjects were cultured in the presence or absence of a protein extract (30 g/ml) from trophoblast lineage cell line Jeg-3 for 5 days as described. 5 Culture supernatants were harvested and tested for IFN-␥ concentration using a ELISA kit (Endogen, Cambridge, MA, USA). The study subjects were grouped by IL1B genotype as indicated: IL1B-511C carrier (C strated positive IFN-␥ production following exposure to a 30-g extract of the trophoblast cell line Jeg-3. Furthermore, there was no correlation between levels of IFN-␥ production in trophoblast-stimulated culures and those of phytohaemagglutinin (PHA) or mixed lymphocytestimulated cultures. Thus, IFN-␥ production in this assay appeared to be a specific response to trophoblast antigens. We also compared PBMC IFN-␥ production to C. albicans antigens (recall antigen) vs trophoblast extract in a separate group of women with RPL (n = 25). We found that C. albicans antigen extracts induced IFN-␥ in all cases except one (median 473 pg/ml, range 0 to 1290, in 18 women who did not have Th1 immunity to trophoblast vs median 384 pg/ml, range 197 to 1253, in seven women who had Th1 immunity to trophoblast, P Ͼ 0.85), suggesting that Th1 immunity to trophoblast does not correlate with immunity to Candida antigens. In addition, Th1 cytokine production by PBMCs in response to trophoblast extracts was not influenced by when in the menstrual cycle the study samples were obtained (Hill JA, unpublished results), which is consistent with relevant data from other published reports, 31 although the levels of IL-4 produced by PBMCs and IL-1 and IL-8 in serum may vary between the two phases of the menstrual cycle. [31] [32] [33] Therefore, Th1 immunity to trophoblast, which is associated with IL1B polymorphism in women with RPL, appears to be a specific memory immune response.
To our knowledge, ours is the first study demonstrating that polymorphisms of a cytokine gene, IL1B are associated with Th1 immunity to trophoblast in women with RPL. Our earlier studies did not reveal any association between RPL and polymorphism of the genes for the Th1 cytokines, IFN-␥ and TNF-␣ (data not shown). Although
Genes and Immunity IL1B polymorphisms have been associated with certain infectious, inflammatory and autoimmune diseases, there was no evidence of infections clinically or by history, cultures and endometrial histology in any of our study subjects. Similarly, histological evidence of inflammation was not observed in any of the decidual samples from these women. Recent observations of decreased endometrial IL-1␤ mRNA levels in the menstrual cycle 24 and during early pregnancy in women with RPL of unknown etiology (Wang Z, Anderson DJ, Hill JA, unpublished results) also do not suggest the involvement of infection or a proinflammatory response.
It was reported that homozygotes for IL1B-511C had lower IL-1␤ production by monocytes stimulated with phorbol 12-myristate 13-acetate (PMA) or antigens, compared with IL1B-511T homozygotes. 13, 34 Although no direct information about IL1B-31T in IL-1␤ production currently exists, the association of homozygosity for IL1B-511C and IL1B-31T with RPL is consistent with the phenotype of low IL-1 production. These variants may theoretically favor reduced endometrial IL-1␤ mRNA levels which was observed in women with RPL. 24 Altered IL-1 production may affect the balance of Th1/Th2 cytokine responsiveness, involving either pregnancy success or failure by two potential mechanisms. First, since IL-1␣ and IL-1␤ are important co-stimulators for Th2 cell proliferation, [16] [17] [18] [19] decidual IL-1 may influence Th2 cell generation. Conversely, low IL-1␤ production at the maternal-fetal interface may reduce Th2-type cytokine production, and thus, in concert with elevated decidual IL-12 levels, favor a Th1-type response to the developing conceptus, which could contribute to early pregnancy failure. This potential mechanism is supported by recent observations in our laboratory of a correlation between reduction of IL-1␤ and an elevated IFN-␥/IL-10 ratio at the mRNA level in the decidua from RPL associated with a chromosomally normal conceptus (Wang Z, Anderson DJ, Hill JA, unpublished results). Altered IL-1␤ production in the decidua may explain the defective production of Th2 cytokines by decidual T cells recently reported in women with RPL. 7 Altered IL-1␤ production may also contribute to pregnancy by directly affecting trophoblast growth and invasion during early pregnancy. These mechanisms are distinct from those in other diseases associated with over-production and pro-inflammatory effects of IL-1.
12,14
The possibility also exists that other gene(s) in linkage disequilibrium with IL1B-511C and IL1B-31T may also play a role. Our data suggest that genetic factors are involved in the regulation of Th1 and Th2-type cytokine responsiveness in reproduction, and that homozygosity for IL1B-511C and IL1B-31T confers susceptibility to RPL associated with Th1-type immunity to trophoblast. Further studies are needed to define the relationship between IL1B polymorphism, production of IL-1␤, and Th1/Th2-type cytokines in the decidua of women with unexplained RPL.
